Chad Messer
Stock Analyst at Lake Street
(0.47)
# 3,856
Out of 4,814 analysts
23
Total ratings
30.43%
Success rate
-29.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.48 | +618.39% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $7.92 | +190.59% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.47 | +1,192.52% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $0.96 | +11,726.95% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $10.22 | +389.24% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $39.48 | +21.58% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $36.06 | -16.81% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $26.67 | +87.48% | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | $31 → $29 | $7.68 | +277.60% | 2 | May 14, 2021 | |
| MREO Mereo BioPharma Group | Initiates: Buy | $10 | $2.31 | +333.84% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $28.32 | +203.67% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.85 | +8,723.53% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $9.32 | +372.10% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $53.79 | +208.61% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $2.06 | +773.79% | 1 | May 5, 2020 |
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.48
Upside: +618.39%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $7.92
Upside: +190.59%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.47
Upside: +1,192.52%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $0.96
Upside: +11,726.95%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $10.22
Upside: +389.24%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $39.48
Upside: +21.58%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $36.06
Upside: -16.81%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $26.67
Upside: +87.48%
CorMedix
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $7.68
Upside: +277.60%
Mereo BioPharma Group
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.31
Upside: +333.84%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $28.32
Upside: +203.67%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $0.85
Upside: +8,723.53%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $9.32
Upside: +372.10%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $53.79
Upside: +208.61%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $2.06
Upside: +773.79%